NCT03524781View on ClinicalTrials.gov

Treatment of Newly Diagnosed Gastroesophageal Reflux Disease in a National Population-based Cohort

CompletedOBSERVATIONAL
Enrollment

36,292

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

January 1, 2019

Study Completion Date

August 1, 2020

Conditions
Gastroesophageal Reflux
Trial Locations (1)

Unknown

Department of Surgery, Kolding Hospital, Kolding

All Listed Sponsors
collaborator

Kolding Sygehus

OTHER

collaborator

Odense Patient Data Explorative Network

OTHER

lead

University of Southern Denmark

OTHER

NCT03524781 - Treatment of Newly Diagnosed Gastroesophageal Reflux Disease in a National Population-based Cohort | Biotech Hunter | Biotech Hunter